Cannabis
Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®
Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) today announced that its wholly-owned subsidiary, Zenabis Ltd., has entered into an agreement with High Park Holdings Ltd. (“High Park”) (the “Supply Agreement”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY) (“Tilray”), pursuant to which High Park will advance CAD $30 million to Zenabis (the “prepaid amount”) in return for a supply of dried cannabis from Zenabis.
Under the terms of the Supply Agreement, Zenabis will deliver a monthly quantity of dried cannabis to High Park commencing in October 2019. Zenabis expects the prepaid amount to be retired within a year. Zenabis does not expect delivery commitments to High Park to impact its ability to supply existing customers. The wholesale pricing under the Supply Agreement will vary depending on the product type and format High Park elects to order.
“Zenabis is well-positioned to supply high-quality cannabis to High Park via this non-dilutive financing arrangement that capitalizes on our rapidly increasing annual cultivation capacity, which we expect to reach 131,200 kg of dried cannabis before deliveries to High Park are scheduled to commence. This Supply Agreement demonstrates the confidence of high-quality counterparties in our ability to produce consistent, premium cannabis product and we are looking forward to fulfilling our commitments to High Park, as well as to our provincial counterparties and the communities in which we operate,” said Andrew Grieve, Chief Executive Officer of Zenabis.
Mr. Grieve continued, “This arrangement significantly reduces the requirement for potential further draws on our $60 million unsecured convertible debenture facility.”
Brownstone Advisors Inc. (“Brownstone”) acted as strategic advisors to Zenabis in connection with the Supply Agreement. Zenabis will pay a strategic advisory fee to Brownstone, which fee will include (subject to receipt of all required regulatory approvals) 319,148 common shares of Zenabis.
SOURCE Zenabis Global Inc.
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis2 weeks ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis7 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis7 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE5 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis5 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis4 days ago
Rubicon Organics Reports Q1 2024 Financial Results